Cargando…

Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years

BACKGROUND/OBJECTIVES: Adequate protein intake is essential to retaining muscle and maintaining physical function, especially in the elderly, and L-Leucine has received attention as an essential amino acid (EAA) that enhances protein retention. The study's aim was to compare the efficacy of EAA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ispoglou, T, White, H, Preston, T, McElhone, S, McKenna, J, Hind, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744242/
https://www.ncbi.nlm.nih.gov/pubmed/26081485
http://dx.doi.org/10.1038/ejcn.2015.91
_version_ 1782414452380925952
author Ispoglou, T
White, H
Preston, T
McElhone, S
McKenna, J
Hind, K
author_facet Ispoglou, T
White, H
Preston, T
McElhone, S
McKenna, J
Hind, K
author_sort Ispoglou, T
collection PubMed
description BACKGROUND/OBJECTIVES: Adequate protein intake is essential to retaining muscle and maintaining physical function, especially in the elderly, and L-Leucine has received attention as an essential amino acid (EAA) that enhances protein retention. The study's aim was to compare the efficacy of EAA mixtures on lean tissue mass (LTM) and functional performance (FP) in a healthy elderly population. SUBJECTS/METHODS: Thirty-six subjects (65–75 years) volunteered to receive capsules with EAAs (Groups A and B containing 20% and 40% L-Leucine, respectively) or placebo (lactose containing 0% L-Leucine, Group C) for 12 weeks. The daily amount ranged from 11 to 21 g (0.21 g/ kg/day) and was taken in two equal dosages alongside food, morning and evening. Main outcomes measured before and after intervention were LTM and FP (30-s arm-curl test; 30-s chair-stand test (30-CST); 6-min walk test (6-WT); and handgrip strength). Secondary outcomes included dietary intakes and physical activity. RESULTS: Twenty-five subjects (11 male and 14 female) completed the study (Group A, n=8; Group B, n=8; Group C, n=9). Gains associated with medium effect sizes were noted in LTM (Group B, 1.1 ±1.1%, P=0.003) and FP (Group A in 30-CST (11.0±11.5%, P=0.02) and 6-WT (8.8±10.0%, P=0.02); Group B in 6-WT (5.8±6.6%, P=0.03) and a trend in 30-CST (13.2±16.0, P=0.06)). Significant differences between groups were not observed in secondary outcomes. CONCLUSIONS: Twice-daily supplementation of EAAs containing 20% or 40% L-Leucine improved aspects of functional status and at the higher level improved LTM. Further work to establish change in a larger sample and palatable supplemental format is now required.
format Online
Article
Text
id pubmed-4744242
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47442422016-02-23 Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years Ispoglou, T White, H Preston, T McElhone, S McKenna, J Hind, K Eur J Clin Nutr Original Article BACKGROUND/OBJECTIVES: Adequate protein intake is essential to retaining muscle and maintaining physical function, especially in the elderly, and L-Leucine has received attention as an essential amino acid (EAA) that enhances protein retention. The study's aim was to compare the efficacy of EAA mixtures on lean tissue mass (LTM) and functional performance (FP) in a healthy elderly population. SUBJECTS/METHODS: Thirty-six subjects (65–75 years) volunteered to receive capsules with EAAs (Groups A and B containing 20% and 40% L-Leucine, respectively) or placebo (lactose containing 0% L-Leucine, Group C) for 12 weeks. The daily amount ranged from 11 to 21 g (0.21 g/ kg/day) and was taken in two equal dosages alongside food, morning and evening. Main outcomes measured before and after intervention were LTM and FP (30-s arm-curl test; 30-s chair-stand test (30-CST); 6-min walk test (6-WT); and handgrip strength). Secondary outcomes included dietary intakes and physical activity. RESULTS: Twenty-five subjects (11 male and 14 female) completed the study (Group A, n=8; Group B, n=8; Group C, n=9). Gains associated with medium effect sizes were noted in LTM (Group B, 1.1 ±1.1%, P=0.003) and FP (Group A in 30-CST (11.0±11.5%, P=0.02) and 6-WT (8.8±10.0%, P=0.02); Group B in 6-WT (5.8±6.6%, P=0.03) and a trend in 30-CST (13.2±16.0, P=0.06)). Significant differences between groups were not observed in secondary outcomes. CONCLUSIONS: Twice-daily supplementation of EAAs containing 20% or 40% L-Leucine improved aspects of functional status and at the higher level improved LTM. Further work to establish change in a larger sample and palatable supplemental format is now required. Nature Publishing Group 2016-02 2015-06-17 /pmc/articles/PMC4744242/ /pubmed/26081485 http://dx.doi.org/10.1038/ejcn.2015.91 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Article
Ispoglou, T
White, H
Preston, T
McElhone, S
McKenna, J
Hind, K
Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years
title Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years
title_full Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years
title_fullStr Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years
title_full_unstemmed Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years
title_short Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years
title_sort double-blind, placebo-controlled pilot trial of l-leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744242/
https://www.ncbi.nlm.nih.gov/pubmed/26081485
http://dx.doi.org/10.1038/ejcn.2015.91
work_keys_str_mv AT ispoglout doubleblindplacebocontrolledpilottrialoflleucineenrichedaminoacidmixturesonbodycompositionandphysicalperformanceinmenandwomenaged6575years
AT whiteh doubleblindplacebocontrolledpilottrialoflleucineenrichedaminoacidmixturesonbodycompositionandphysicalperformanceinmenandwomenaged6575years
AT prestont doubleblindplacebocontrolledpilottrialoflleucineenrichedaminoacidmixturesonbodycompositionandphysicalperformanceinmenandwomenaged6575years
AT mcelhones doubleblindplacebocontrolledpilottrialoflleucineenrichedaminoacidmixturesonbodycompositionandphysicalperformanceinmenandwomenaged6575years
AT mckennaj doubleblindplacebocontrolledpilottrialoflleucineenrichedaminoacidmixturesonbodycompositionandphysicalperformanceinmenandwomenaged6575years
AT hindk doubleblindplacebocontrolledpilottrialoflleucineenrichedaminoacidmixturesonbodycompositionandphysicalperformanceinmenandwomenaged6575years